N/A
N=113
Effects of Aromatherapy on Nausea Levels
Nausea, Postoperative
Bottom Line
View on ClinicalTrials.gov: NCT04882501 ↗Enrolled (actual)
113
Serious AEs
0.0%
Results posted
Nov 2024
Primary outcome: Primary: Patient Reported Nausea as Measured Visual Analog Scale (VAS) From 0-3 — 0; 0; 13; 13 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- QUEASEEase aromatherapy quick tab (Other); Placebo product (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Inova Health Care Services
- Primary completion
- Aug 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Patient Reported Nausea as Measured Visual Analog Scale (VAS) From 0-3 |
0; 0; 13; 13; 27; 25 | — |
| SECONDARY Total Number of Participants Who Received an Anti-emetic Post Study Intervention. |
48; 50 | — |
Summary
Aromatherapy is the therapeutic use of essential oils from plants for the improvement of physical, emotional, and spiritual well-being. Healthcare providers play an important role in improving the care of patients with nausea. Aromatherapy is a complementary therapy that may help with post-operative nausea in the adult post-operative bariatric patient population.
The purpose of this study is to evaluate the effects of aromatherapy intervention on nausea levels with post-operative bariatric patients once they are on the surgical unit.
Eligibility Criteria
Inclusion Criteria
- Patients ≥ 18 years of age admitted to the Surgical Unit who are experiencing an initial episode of nausea status post laparoscopic/ robotic sleeve gastrectomy, and/or laparoscopic/robotic Roux-En-Y (RNY) surgery, and/or revisional bariatric surgery; must be able to read and speak English; able to follow directions; bariatric surgeon is part of Inova Medical Group (IMG) and patient is an inpatient.
Exclusion Criteria
- Patients < 18 years of age; non-English speaking; not able to follow directions; inability to smell (anosmia); allergy to peppermint, spearmint, ginger and/or lavender; receiving bariatric surgery for gastroparesis; pregnant or breastfeeding; vulnerable subjects; receiving complementary therapy (healing touch and/or music therapy) or presently enrolled in another research study.
Data sourced from ClinicalTrials.gov (NCT04882501). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.